Brain/Nerve Tumor Cells
Brain and nerve tumors originate from diverse cell types within the central and peripheral nervous systems, including glial cells, neurons, and nerve sheath components. These tumors encompass a wide spectrum of diseases, such as gliomas, neuroblastomas, meningiomas, and schwannomas, each with distinct biological behaviors and levels of malignancy.
Our brain/nerve tumor cell line collection provides physiologically relevant in vitro models for studying tumor heterogeneity, neural lineage differentiation, and mechanisms of tumor progression, as well as for evaluating therapeutic strategies targeting cancers of the nervous system.
Reliable Authentic Diverse Supported
Key Features & Expertise
Our brain and nerve tumor cell lines are designed to support advanced neuro-oncology research
Broad Representation of Nervous System Tumors
- Includes glioma, neuroblastoma, meningioma, and schwannoma models
- Covers both central and peripheral nervous system tumor types
- Supports studies across benign and malignant disease contexts
Reflective of Cellular and Molecular Heterogeneity
- Models derived from distinct neural lineages, including glial and neural crest origins
- Capture variability in differentiation status and tumor aggressiveness
- Applicable to studies of tumor evolution, signaling pathways, and resistance mechanisms
Validated Quality for Research Applications
- STR-authenticated to ensure cell line identity
- Mycoplasma-free and rigorously quality controlled
- Reliable performance in drug screening and mechanistic studies
FAQ
What types of brain and nerve tumor cell lines are included?
This collection includes a variety of tumor models such as glioma (including astrocytoma and glioblastoma), neuroblastoma, meningioma, and schwannoma cell lines, representing both central and peripheral nervous system tumors.
How do I select the right model for my research?
Model selection depends on your research goals. Key considerations include:
- Tumor origin (central vs. peripheral nervous system)
- Cell lineage (glial vs. neuronal vs. neural crest-derived)
- Malignancy grade and growth characteristics
- Relevance to your therapeutic or mechanistic study
What makes brain and nerve tumor models challenging to study?
These tumors are highly heterogeneous, with diverse genetic and cellular features. Their complex microenvironment and lineage diversity can make experimental interpretation more challenging compared to other tumor types.
Can these cell lines be used for drug discovery?
Yes, brain and nerve tumor cell lines are widely used in drug discovery and screening, enabling evaluation of therapeutic efficacy, mechanism of action, and subtype-specific responses in neuro-oncology research.
Do these models reflect tumor heterogeneity?
While individual cell lines represent specific tumor characteristics, using a panel of models allows researchers to capture the diversity of nervous system tumors, including differences in lineage, differentiation state, and aggressiveness.
Is molecular characterization data available?
For many cell lines, relevant characterization data such as mutation profiles and pathway information are available, supporting informed model selection and experimental design.
How should these cell lines be stored and handled?
Cell lines are typically supplied as cryopreserved vials or shipped on dry ice. Upon receipt, they should be stored in liquid nitrogen and handled using standard cell culture protocols to ensure optimal viability and consistency.